Summit Therapeutics Inc (SMMT) Company Profile & Statistics

Summit Therapeutics Inc
SMMT
(Nasdaq - US)
N/A
4.61
-0.17 (-3.56%)
in:usd•As of: May 10, 2024 12:46 UTC -4
Open
4.83
High
4.98
Low
4.61

About Summit Therapeutics Inc

CEO

Robert W. Duggan

Headquarters

601 brickell key drive, suite 1000

miami, fl 33131, united states

Auditor

PricewaterhouseCoopers LLP

Employees

105

Share Holders

178

Website

www.summittxinc.com

Industry

biotechnology

Sector

health technology

Company Overview

Summit Therapeutics PLC is engaged in the discovery and development of drug to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics PLC is headquartered in Abingdon, the United Kingdom.

Summit Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	3.24B
Enterprise Value	3.26B
Enterprise Value/EBITDA (ttm)	-5.37
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	78.76
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-125.07%
Return on Invested Capital (ttm)	-280.98%
Return on Assets (ttm)	-51.02%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-607.60M
Net Income Avi to Common (ttm)	-614.93M
Diluted EPS (ttm)	-0.16

Share Statistics

Beta (5Y Monthly)	-1.13
52-Week Change	117.45%
S&P500 52-Week Change	26.10%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	701.70M
Dividend Yield	0.00%
Float ⁴	114.42M
% Held by Insiders	83.70%
% Held by Institutions	4.61%

Balance Sheet

Total Cash (mrq)	186.24M
Total Cash Per Share (mrq)	0.27
Total Debt (mrq)	100.00M
Total Debt/Equity (mrq)	128.71%
Current Ratio (mrq)	9.30%
Quick Ratio (mrq)	6.97%
Book Value Per Share (mrq)	0.11

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.12
Free Cash Flow (ytd)	-76.66M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Summit Therapeutics Inc

Trade With A Regulated Broker